Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL28959686

O=C(O)C(F)(F)F.O=CN1CCOCC1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
KCNJ1 P48048 1/20 0.38
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
RAB9A P51151 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35
HSP90AA1 P07900 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
DPP4 P27487 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
FKBP1A P62942 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25410143 0.83 RECQL (0.36) L3MBTL1ALDH1A1RECQLSMN1; SMN2RAB9A
Trifluoroacetic Acid SCHEMBL28709650 0.83 HSD17B10 (0.39) ALDH1A1HSD17B10RAB9ADPP4DPP7
Trifluoroacetic Acid SCHEMBL30636582 0.81 HSD17B10 (0.42) ALDH1A1HSD17B10RAB9AMEN1POLB
SCHEMBL11841381 0.80
SCHEMBL7321 0.80
Formic Acid SCHEMBL17969575 0.78 RECQL (0.37) L3MBTL1ALDH1A1HSD17B10RECQLSMN1; SMN2
Hydrochloric Acid SCHEMBL5012159 0.78
Hydrochloric Acid SCHEMBL3855161 0.78 CA12 (0.38) L3MBTL1ALDH1A1RECQLSMN1; SMN2RAB9A
SCHEMBL13434243 0.78 SMN1; SMN2 (0.39) L3MBTL1ALDH1A1HSD17B10RECQLSMN1; SMN2
SCHEMBL16607618 0.78 SMN1; SMN2 (0.39) L3MBTL1ALDH1A1HSD17B10RECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115715289-B Polyarylate and application thereof 江苏先声药业有限公司 2024-12-03 CN disclosed
US-20230310445-A1 LOX ENZYME INHIBITING METHODS AND COMPOSITIONS ANOVIA BIOSCIENCES, INC. 2023-10-05 US disclosed
EP-4138824-A1 LOX ENZYME INHIBITING METHODS AND COMPOSITIONS Anovia Biosciences, Inc. (US) 2023-03-01 EP disclosed
CN-115715289-A Polyarylate and use thereof 江苏先声药业有限公司 2023-02-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230310445-A1 LOX ENZYME INHIBITING METHODS AND COMPOSITIONS LOX, LOXL1, LOXL2 L3MBTL1 460/4885KCNJ1 4584/4885ALDH1A1 487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.